Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cellectis SA ADR buy Quitte

Cellectis SA ADR
Start price
€21.07
29.02.16 / 50%
Target price
€24.35
18.03.16
Performance (%)
15.63%
End price
€24.36
18.03.16
Summary
This prediction ended on 18.03.16 with a price of €24.36. The prediction had a final performance of 15.63%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Cellectis SA ADR 11.864% 11.864% 11.864% 54.386%
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

Comments by Quitte for this prediction

In the thread Cellectis SA ADR diskutieren
Prediction Buy
Perf. (%) 15.63%
Target price 24.354
Change
Ends at 18.03.16

gutes Rating und eventuell ein Boden

Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.

Quitte 
0
Report Share
29.02.16
Prediction Buy
Perf. (%) 15.63%
Target price 24.354
Change
Ends at 18.03.16

(Zielkurs erreicht)

Quitte 
0
Report Share
18.03.16